SG pharma firms delay US expansion amidst tariff clarifications: Minister Gan
The new tariffs were put on hold so companies could negotiate exemptions with US officials.
Numerous drug companies are pausing their plans to expand in the US until the American government clarifies if they will be exempted from new tariffs, Minister Gan Siow Huang told the Parliament on Tuesday.
The new tariffs were put on hold so companies could negotiate exemptions with US officials.
Specifically, many Singapore-based pharmaceutical companies intending to build or enlarge their US facilities need further guidance to confirm their projects will qualify for that exemption.
Gan mentioned that Singapore is currently negotiating a special, favourable tariff agreement with the US for its drug exports.
She clarified that the majority of what Singapore exports to the US in this sector is active pharmaceutical ingredients, not ready-to-use medications like tablets or capsules.